Literature DB >> 3702590

Calcitonin secreting property of ipriflavone in the presence of estrogen.

I Yamazaki, M Kinoshita.   

Abstract

Calcitonin secretion is influenced by estrogen. In the present study, basal and calcium-stimulated serum calcitonin levels were reduced in ovariectomized rats, and replacement estrogen administered for 3 weeks increased both calcitonin levels to those in intact rats. Ipriflavone, 7-isopropoxy-3-phenyl-4H-1-benzopyran-4-one, alone did not influence either calcitonin level. However, ipriflavone and subeffective doses of estrogen administered simultaneously increased both levels; the increase depended upon the dose of ipriflavone. Furthermore, pretreatment with estrone resulted in greater calcitonin release in response to various doses of calcium and pretreatment with estrone and ipriflavone caused an even greater release. These findings indicate that ipriflavone increases the sensitivity of the thyroid gland to estrogen to secrete calcitonin in response to calcium.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3702590     DOI: 10.1016/0024-3205(86)90492-3

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  15 in total

1.  Elevation of serum theophylline levels by ipriflavone in a patient with chronic obstructive pulmonary disease.

Authors:  J Takahashi; K Kawakatsu; T Wakayama; H Sawaoka
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

2.  Prevention of early postmenopausal bone loss using low doses of conjugated estrogens and the non-hormonal, bone-active drug ipriflavone.

Authors:  D Agnusdei; C Gennari; L Bufalino
Journal:  Osteoporos Int       Date:  1995       Impact factor: 4.507

3.  Tamoxifen stimulates calcitonin-producing thyroid C-cells and prevents trabecular bone loss in a rat model of androgen deficiency.

Authors:  Branko Filipović; Branka Šošić-Jurjević; Vladimir Ajdžanović; Jasmina Živanović; Esma Isenović; Florina Popovska-Perčinić; Verica Milošević
Journal:  J Anat       Date:  2015-04-07       Impact factor: 2.610

4.  Lack of effect of ipriflavone on osteoclast motility and bone resorption in in vitro and ex vivo studies.

Authors:  M Azria; C Behhar; S Cooper
Journal:  Calcif Tissue Int       Date:  1993-01       Impact factor: 4.333

5.  The thyroid C cells of ovariectomized rats treated with estradiol.

Authors:  B Filipović; B Sosić-Jurjević; N Nestorović; M Manojlović Stojanoski; N Kostić; V Milosević; M Sekulić
Journal:  Histochem Cell Biol       Date:  2003-10-17       Impact factor: 4.304

6.  The effect of ipriflavone and its main metabolites on theophylline biotransformation.

Authors:  K Monostory; L Vereczkey
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1996 Jan-Mar       Impact factor: 2.441

7.  Effect of ipriflavone on bone mineral density and calcium-related factors in elderly females.

Authors:  S Nakamura; S Morimoto; S Takamoto; T Onishi; K Fukuo; E Koh; S Kitano; Y Miyashita; O Yasuda; M Tamatani
Journal:  Calcif Tissue Int       Date:  1992       Impact factor: 4.333

8.  Histochemical and fine structural study of bone of ipriflavone-treated rats.

Authors:  H Ozawa; H Nakamura; K Irie; M Irie
Journal:  Calcif Tissue Int       Date:  1992       Impact factor: 4.333

9.  Effect of ipriflavone and estrogen on the differentiation and proliferation of osteogenic cells.

Authors:  Y Kakai; T Kawase; T Nakano; Y Mikuni-Takagaki; S Saito
Journal:  Calcif Tissue Int       Date:  1992       Impact factor: 4.333

10.  Effects of ipriflavone on calcitonin synthesis in C cells of the rat thyroid.

Authors:  K Watanabe; S Takekoshi; K Kakudo
Journal:  Calcif Tissue Int       Date:  1992       Impact factor: 4.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.